Ind Swift Ltd received DCGI approval for manufacturing anti-infective Clarithomycin Clarie-SR.
The company filed international patent for the drug in the US, Europe, Latin America, Canada and other Asian Countries.
BSE code: 524652
February 27, 2003 19:37 IST
Ind Swift Ltd received DCGI approval for manufacturing anti-infective Clarithomycin Clarie-SR.
The company filed international patent for the drug in the US, Europe, Latin America, Canada and other Asian Countries.
BSE code: 524652
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances
